Founded in 2009, Transcell Biologics operates in Health Tech industry. Initially focusing on stem cell research and regenerative medicine, the company has evolved its offerings to include proprietary ...
Funding stage:
Undisclosed
Last funding:
08/09/2024
Investors
Transcell Biologics: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders2
Latest Filing Date30 March 2018- Funding Events1
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Transcell Biologics
As of 31 March 2018, Transcell Biologics's equity is held by 2 shareholders, with the top three being Transcell Biologics Pvt Ltd and Mrs.Subhadra Dravida.
Transcell Biologics Pvt Ltd holds the largest stake in Transcell Biologics at 80.0% as of 31 March 2018.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links